Medicine and Dentistry
Acute Lymphoblastic Leukemia
88%
Biological Marker
35%
Body Mass Index
24%
Bone Metastasis
34%
Cancer Surgery
60%
Chemotherapy
39%
Childhood Cancer
87%
Cohort Analysis
45%
Colorectal Carcinoma
49%
Cross Sectional Study
25%
Cumulative Incidence
36%
Dexamethasone
32%
Disease
38%
Distant Metastasis
27%
Event Free Survival
47%
Ewing Sarcoma
22%
Frailty
27%
Ganglioneuroblastoma
50%
Hazard Ratio
42%
Hip
25%
Hip Replacement
23%
Implant
23%
Knee
29%
Malignant Neoplasm
35%
Meta-Analysis
68%
Minimal Residual Disease
27%
Neoplasm
47%
Odds Ratio
32%
Oncology
28%
Osteosarcoma
59%
Overall Survival
96%
Pediatrics
76%
Pediatrics Patient
21%
Primary Health Care
23%
Prognostic Factor
51%
Proportional Hazards Model
42%
Prospective Study
27%
Quality of Life
54%
Radiation Therapy
33%
Radiostereometric Analysis
21%
Randomized Controlled Trial
35%
Recurrent Disease
44%
Retrospective Cohort Study
29%
Retrospective Study
32%
Rhabdomyosarcoma
22%
Sarcopenia
27%
Soft Tissue Sarcoma
91%
Surgery
30%
Systematic Review
77%
Total Knee Arthroplasty
23%
Keyphrases
5-year Survival
21%
Acute Lymphoblastic Leukemia
65%
Bilateral Sagittal Split Osteotomy
22%
Bone Sarcoma
23%
Chemotherapy
29%
Childhood Cancer Survivors
24%
Clinical Outcomes
28%
Clinical Trials
23%
Colorectal Cancer
21%
Colorectal Cancer Surgery
49%
Competing Risks
31%
Confidence Interval
96%
Contact Process
22%
Cumulative Incidence
30%
Distant Metastasis
27%
Dutch
92%
Event-free Survival
46%
Ewing Sarcoma
21%
Extremity Soft Tissue Sarcoma
38%
Frailty
28%
Hazard Ratio
31%
Health-related Quality of Life
30%
High Risk
37%
Knee
24%
Local Recurrence
35%
Meta-analysis
100%
Minimal Residual Disease
26%
Multistate Model
40%
Netherlands
36%
Neuroblastoma
38%
Odds Ratio
31%
Oncology
23%
Osteosarcoma
37%
Overall Survival
96%
Pediatric Acute Lymphoblastic Leukemia
34%
Prognostic Factors
50%
Radiostereometric Analysis
22%
Radiotherapy
34%
Randomized Controlled Trial
39%
Risk Factors
54%
Risk Model
31%
Sarcopenia
30%
Soft Tissue Sarcoma
37%
Survival Analysis
21%
Systematic Meta-analysis
48%
Total Hip Arthroplasty
24%
Total Hip Replacement
23%
Total Knee Arthroplasty
23%
Tumor
23%
Working Diagnosis
29%